Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · IEX Real-Time Price · USD
13.12
+0.78 (6.32%)
At close: Apr 26, 2024, 4:00 PM
11.95
-1.17 (-8.92%)
After-hours: Apr 26, 2024, 6:46 PM EDT

Greenwich LifeSciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018
Market Capitalization
169135195319438--
Market Cap Growth
--30.79%-38.84%-27.16%---
Enterprise Value
16212818229241010
PE Ratio
-15.20-15.20-24.96-69.86-235.29--
PB Ratio
25.2220.1714.7811.9015.86--
P/FCF Ratio
-20.86-20.86-31.50-74.40-380.18--
P/OCF Ratio
-20.86-20.86-31.50-74.40-380.18--
EV/EBITDA Ratio
-14.42-14.42-23.25-63.96-220.48-0.18-0.20
EV/EBIT Ratio
-14.41-14.41-23.24-63.91-220.05-0.18-0.20
EV/FCF Ratio
-19.78-19.78-29.33-68.06-355.56-2.14-2.91
Debt / Equity Ratio
----0.01-0.47-0.04
Debt / EBITDA Ratio
-----0.15-0.19-0.25
Debt / FCF Ratio
-----0.24-2.17-3.66
Quick Ratio
23.7423.7451.2370.6327.410.000.12
Current Ratio
23.7623.7651.2670.6627.430.010.12
Return on Equity (ROE)
-93.90%-93.90%-48.10%-16.00%-14.20%59.70%-
Return on Assets (ROA)
-91.20%-91.20%-47.40%-15.70%-13.00%-5066.40%-
Return on Capital (ROIC)
-139.21%-139.21%-60.85%-17.14%-6.68%478.89%17.42%
Earnings Yield
-5.26%-6.58%-4.01%-1.43%-0.43%--
FCF Yield
-3.83%-4.79%-3.17%-1.34%-0.26%--
Buyback Yield / Dilution
0.51%0.51%0.23%-36.27%-320.69%-1012.33%-
Total Shareholder Return
0.51%0.51%0.23%-36.27%-320.69%-1012.33%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).